152 related articles for article (PubMed ID: 23653393)
1. A rapid membrane potential assay to monitor CFTR function and inhibition.
Maitra R; Sivashanmugam P; Warner K
J Biomol Screen; 2013 Oct; 18(9):1132-7. PubMed ID: 23653393
[TBL] [Abstract][Full Text] [Related]
2. A Homogeneous Cell-Based Halide-Sensitive Yellow Fluorescence Protein Assay to Identify Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Ion Channel.
Smith E; Giuliano KA; Shumate J; Baillargeon P; McEwan B; Cullen MD; Miller JP; Drew L; Scampavia L; Spicer TP
Assay Drug Dev Technol; 2017 Dec; 15(8):395-406. PubMed ID: 29172645
[TBL] [Abstract][Full Text] [Related]
3. Simple image-based no-wash method for quantitative detection of surface expressed CFTR.
Larsen MB; Hu J; Frizzell RA; Watkins SC
Methods; 2016 Mar; 96():40-45. PubMed ID: 26361332
[TBL] [Abstract][Full Text] [Related]
4. High-throughput screening of libraries of compounds to identify CFTR modulators.
Pedemonte N; Zegarra-Moran O; Galietta LJ
Methods Mol Biol; 2011; 741():13-21. PubMed ID: 21594775
[TBL] [Abstract][Full Text] [Related]
5. CFTR inhibitors.
Verkman AS; Synder D; Tradtrantip L; Thiagarajah JR; Anderson MO
Curr Pharm Des; 2013; 19(19):3529-41. PubMed ID: 23331030
[TBL] [Abstract][Full Text] [Related]
6. CFTR chloride channel drug discovery--inhibitors as antidiarrheals and activators for therapy of cystic fibrosis.
Verkman AS; Lukacs GL; Galietta LJ
Curr Pharm Des; 2006; 12(18):2235-47. PubMed ID: 16787252
[TBL] [Abstract][Full Text] [Related]
7. Improved fluorescence assays to measure the defects associated with F508del-CFTR allow identification of new active compounds.
Langron E; Simone MI; Delalande CM; Reymond JL; Selwood DL; Vergani P
Br J Pharmacol; 2017 Apr; 174(7):525-539. PubMed ID: 28094839
[TBL] [Abstract][Full Text] [Related]
8. Activation of the cystic fibrosis transmembrane conductance regulator by the flavonoid quercetin: potential use as a biomarker of ΔF508 cystic fibrosis transmembrane conductance regulator rescue.
Pyle LC; Fulton JC; Sloane PA; Backer K; Mazur M; Prasain J; Barnes S; Clancy JP; Rowe SM
Am J Respir Cell Mol Biol; 2010 Nov; 43(5):607-16. PubMed ID: 20042712
[TBL] [Abstract][Full Text] [Related]
9. Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Chung WJ; Goeckeler-Fried JL; Havasi V; Chiang A; Rowe SM; Plyler ZE; Hong JS; Mazur M; Piazza GA; Keeton AB; White EL; Rasmussen L; Weissman AM; Denny RA; Brodsky JL; Sorscher EJ
PLoS One; 2016; 11(10):e0163615. PubMed ID: 27732613
[TBL] [Abstract][Full Text] [Related]
10. Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis.
Cai ZW; Liu J; Li HY; Sheppard DN
Acta Pharmacol Sin; 2011 Jun; 32(6):693-701. PubMed ID: 21642944
[TBL] [Abstract][Full Text] [Related]
11. Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice.
Dhooghe B; Noël S; Bouzin C; Behets-Wydemans G; Leal T
PLoS One; 2013; 8(10):e77314. PubMed ID: 24204804
[TBL] [Abstract][Full Text] [Related]
12. Converting nonhydrolyzable nucleotides to strong cystic fibrosis transmembrane conductance regulator (CFTR) agonists by gain of function (GOF) mutations.
Okeyo G; Wang W; Wei S; Kirk KL
J Biol Chem; 2013 Jun; 288(24):17122-33. PubMed ID: 23620589
[TBL] [Abstract][Full Text] [Related]
13. Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy.
Hall JD; Wang H; Byrnes LJ; Shanker S; Wang K; Efremov IV; Chong PA; Forman-Kay JD; Aulabaugh AE
Protein Sci; 2016 Feb; 25(2):360-73. PubMed ID: 26444971
[TBL] [Abstract][Full Text] [Related]
14. Low temperature and chemical rescue affect molecular proximity of DeltaF508-cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC).
Qadri YJ; Cormet-Boyaka E; Rooj AK; Lee W; Parpura V; Fuller CM; Berdiev BK
J Biol Chem; 2012 May; 287(20):16781-90. PubMed ID: 22442149
[TBL] [Abstract][Full Text] [Related]
15. Use of a membrane potential-sensitive probe to assess biological expression of the cystic fibrosis transmembrane conductance regulator.
Renier M; Tamanini A; Nicolis E; Rolfini R; Imler JL; Pavirani A; Cabrini G
Hum Gene Ther; 1995 Oct; 6(10):1275-83. PubMed ID: 8590731
[TBL] [Abstract][Full Text] [Related]
16. Role of tyrosine phosphorylation in the muscarinic activation of the cystic fibrosis transmembrane conductance regulator (CFTR).
Billet A; Luo Y; Balghi H; Hanrahan JW
J Biol Chem; 2013 Jul; 288(30):21815-23. PubMed ID: 23760269
[TBL] [Abstract][Full Text] [Related]
17. Identification of Compounds That Promote Readthrough of Premature Termination Codons in the CFTR.
Smith E; Dukovski D; Shumate J; Scampavia L; Miller JP; Spicer TP
SLAS Discov; 2021 Feb; 26(2):205-215. PubMed ID: 33016182
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stem Cell exosome delivered Zinc Finger Protein activation of cystic fibrosis transmembrane conductance regulator.
Villamizar O; Waters SA; Scott T; Grepo N; Jaffe A; Morris KV
J Extracell Vesicles; 2021 Jan; 10(3):e12053. PubMed ID: 33532041
[TBL] [Abstract][Full Text] [Related]
19. Small molecule-facilitated anion transporters in cells for a novel therapeutic approach to cystic fibrosis.
Fiore M; Cossu C; Capurro V; Picco C; Ludovico A; Mielczarek M; Carreira-Barral I; Caci E; Baroni D; Quesada R; Moran O
Br J Pharmacol; 2019 Jun; 176(11):1764-1779. PubMed ID: 30825185
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis.
Lambert JA; Raju SV; Tang LP; McNicholas CM; Li Y; Courville CA; Farris RF; Coricor GE; Smoot LH; Mazur MM; Dransfield MT; Bolger GB; Rowe SM
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):549-58. PubMed ID: 24106801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
